DE VITA, Ferdinando

DE VITA, Ferdinando  

Dipartimento di Medicina di Precisione  

Mostra records
Risultati 1 - 20 di 250 (tempo di esecuzione: 0.013 secondi).
Titolo Data di pubblicazione Autore(i) File
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant 1-gen-2019 De Falco, V.; Natalicchio, M. I.; Napolitano, S.; Coppola, N.; Conzo, G.; Martinelli, E.; Zanaletti, N.; Vitale, P.; Giunta, E. F.; Vietri, M. T.; Vitiello, P. P.; Ciardiello, D.; Marinaccio, A.; De Vita, F.; Ciardiello, F.; Troiani, T.
A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases. 1-gen-2014 Aurilio, G; Disalvatore, D; Pruneri, G; Bagnardi, V; Viale, G; Curigliano, G; Adamoli, L; Munzone, E; Sciandivasci, A; DE VITA, Ferdinando; Goldhirsch, A; Nolè, F.
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer 1-gen-2011 DE VITA, Ferdinando; Orditura, Michele; Martinelli, Erika; Vecchione, L; Innocenti, R; Sileni, Vc; Pinto, C; Di Maio, M; Farella, A; Troiani, Teresa; Morgillo, Floriana; Napolitano, Vincenzo; Ancona, E; Di Martino, N; Ruol, A; Galizia, Gennaro; Del Genio, A; Ciardiello, Fortunato
A rare case of extraovarian primary peritoneal carcinoma in a 72 year-old woman 1-gen-2010 Moccia, F; Cimmino, M; Santabarbara, G; DE VITA, Ferdinando; Trapani, V; Romano, G; Fei, Landino
A true splenic cyst producing carboydrate antigen 19-9 and cancer antigen 50 and 125,but not interleukin 10 1-gen-2003 Galizia, Gennaro; Lieto, Eva; Ferraraccio, Franca; P., Castellano; DE VITA, Ferdinando; C., Pignatelli
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC 1-gen-2019 Ciaramella, Vincenza; Sasso, Ferdinando Carlo; DI Liello, Raimondo; Corte, Carminia Maria Della; Barra, Giusi; Viscardi, Giuseppe; Esposito, Giovanna; Sparano, Francesca; Troiani, Teresa; Martinelli, Erika; Orditura, Michele; De Vita, Ferdinando; Ciardiello, Fortunato; Morgillo, Floriana
Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: A randomised study by the Southern Italy Cooperative Oncology Group 1-gen-2002 Comella, P; Crucitta, E; DE VITA, Ferdinando; DE LUCIA, L; Farris, A; DEL GAIZO, F; Palmeri, S; Iannelli, A; Mancarella, S; Tafuto, S; Maiorino, L; Buzzi, F; DE CATALDIS, G; Casaretti, R; Avallone, A; Montella, M; Comella, G; Orditura, Michele; Catalano, G; Lorusso, V; DE LENA, M; Biglietto, M; Sanna, G; Sarobba, Mg; Belli, C; Russo, A; Pizzardi, V; Accurso, V; Musca, A; Gravina, A; Leopaldi, G; Brunetti, C; Muci, D; Leo, S; Avino, F; DE LUCA, L; Greco, E; Aiello, C.
Adjuvant chemoradiotherapy in patients with stage III-IV radically resected gastric cancer: a pilot study 1-gen-2010 Orditura, Michele; DE VITA, Ferdinando; Muto, P; Vitiello, F; Murino, P; Lieto, Eva; Vecchione, L; Romano, A; Martinelli, Erika; Renda, A; Ferraraccio, Franca; DEL GENIO, A; Ciardiello, Fortunato; Galizia, Gennaro
Adjuvant chemotherapy of gastric cancer: which regimen? 1-gen-2005 DE VITA, Ferdinando; Orditura, Michele; Ciardiello, Fortunato; Catalano, G.
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) 1-gen-2007 DE VITA, Ferdinando; Giuliani, F; Orditura, Michele; Maiello, E; Galizia, Gennaro; DI MARTINO, Natale; Montemurro, F; Carten, G; Manzione, L; Romito, S; Gebbia, V; Ciardiello, Fortunato; Catalano, G; Colucci, G; GRUPPO ONCOLOGICO ITALIA, Meridionale
Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting 1-gen-2021 Pappalardo, A.; Giunta, E. F.; Tirino, G.; Pompella, L.; Federico, P.; Daniele, B.; De Vita, F.; Petrillo, A.
Adult Wilms' tumor: a case report 1-gen-1997 Orditura, Michele; DE VITA, Ferdinando; Catalano, G.
Amifostine: a selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review) 1-gen-1999 Orditura, Michele; DE VITA, Ferdinando; Ciaramella, F; Roscigno, A; Infusino, S; Auriemma, A; Abbate, G; Catalano, G.
Analysis of interleukin-2/interleukin-2 receptor system in advanced non-small-cell lung cancer 1-gen-1998 DE VITA, Ferdinando; Turitto, G; DI GRAZIA, M; Frattolillo, A; Catalano, G.
Analysis of neurothelin expression in neoplastic cells derived from gastrointestinal tract tumors 1-gen-1999 Catalano, G.; Roscigno, A.; DE VITA, Ferdinando; Orditura, M.; Infusino, F.; Auriemma, A.; Bontempo, Paola; Tortora, V.; Molinari, Anna Maria; AND SCHIAVONE, E. M.
Analysis of recovery time indexes in 5-fluorouracil-treated cancer patients 1-gen-1998 Orditura, Michele; DE VITA, Ferdinando; Sarubbi, B; Ducceschi, V; Auriemma, A; Infusino, S; Iacono, A; Catalano, G.
Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion 1-gen-1994 Orditura, Michele; DE VITA, Ferdinando; Ciaramella, F; Catalano, G.
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy. 1-gen-2009 Martinelli, Erika; DE PALMA, Raffaele; Orditura, Michele; DE VITA, Ferdinando; Ciardiello, Fortunato
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors 1-gen-2011 Morgillo, Floriana; D'Aiuto, E; Troiani, Teresa; Martinelli, Erika; Cascone, T; DE PALMA, Raffaele; Orditura, Michele; DE VITA, Ferdinando; Ciardiello, Fortunato
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors. 1-gen-2011 Morgillo, Floriana; Martinelli, Erika; Troiani, Teresa; Orditura, Michele; DE VITA, Ferdinando; Ciardiello, Fortunato; Ciardiello, F.